Axogen Inc (AXGN) Peer Comparison

$50.17

$0.80 (1.62%)

As on 02-Nov-2026 11:33EST

Market cap

$2,949 Mln

Revenue (TTM)

$267 Mln

P/E Ratio

--

P/B Ratio

5.9

Div. Yield

0 %

Edit

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Market cap ($ Mln)	2,949	12,682	10,876	11,234	14,302
Revenue ($ Mln)	267	1,560	6,636	806	690
Net Profit ($ Mln)	-31.92	157.02	337.20	-11.80	-169.80
Net Margin (%)	-11.96	10.06	5.08	-1.47	-24.60
RoE (%)	-8.62	10.27	5.90	-0.56	-24.46
Price to Earnings	--	79.11	32.10	--	--
Price-To-Book	5.94	8.19	1.94	5.37	20.01

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Operating Revenue	266.93	1,560.33	6,635.60	805.61	690.33
Cost of Revenue	68.92	499.55	4,539.20	394.34	130.29
Gross Profit	167.35	942.44	2,139.40	347.62	393.22
Operating Expenses	211.81	871.54	1,593.70	392.34	623.34
Operating Profit (EBIT)	-13.81	189.25	502.70	18.93	-63.30
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-31.92	207.82	315.50	8.23	-174.52
Provision for Tax	0.00	50.81	-21.70	20.03	-4.72
Profit after Tax (Net Income)	-31.92	157.02	337.20	-11.80	-169.80
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	47.34	0.00	0.00	0.00

Liabilities ($ Mln)

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Shareholder's Funds	496.10	1,583.51	5,835.90	2,091.74	717.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	17.78	207.78	4,425.10	708.99	135.53
Current Liabilities	36.46	233.81	1,369.00	125.69	126.73
Total Liabilities	221.69	1,826.52	11,794.70	2,949.70	893.49

Assets ($ Mln)

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Non-Current Assets	112.25	648.47	9,037.40	1,684.42	399.88
Current Assets	438.09	1,376.63	2,592.60	1,241.98	579.65
Total Assets	221.69	1,826.52	11,794.70	2,949.70	893.49
Total Debt*	19.47	209.39	3,683.80	692.24	101.98
Net Current Assets	0.00	0.00	1,223.60	0.00	452.92

Cashflow ($ Mln)

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Cash From Operating Activities	0.81	238.66	623.80	117.42	-46.34
Cash Flow from Investing Activities	-5.32	-404.59	-130.50	-298.47	-77.61
Cash from Financing Activities	10.50	26.53	-409.40	-15.21	11.89
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
ROCE (%)	-8.51	11.76	-5.43	1.79	-22.53
ROE (%)	-8.62	10.27	5.90	-0.56	-24.46
ROA (%)	-5.18	5.91	2.57	-0.33	-15.48
EBIT Margin (%)	-11.29	13.40	7.39	4.20	-24.51
Net Margin (%)	-11.96	10.06	5.08	-1.47	-24.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Revenue Growth (%)	24.32	16.98	0.92	13.80	46.94
EBIT Growth (%)	-313.20	11.72	106.97	29.47	-106.70
Net Profit Growth (%)	-1,422.27	-4.27	510.22	-779.17	-93.80
EPS Growth (%)	-1,274.08	-4.95	507.22	-910.66	-90.00
Book Value Growth (%)	206.40	15.61	4.89	0.35	-12.58

Valuation Ratios

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Price / Earnings	-97.82	68.93	-14.68	189.42	-34.59
Price / Book Value	11.92	8.58	1.40	4.40	9.90
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	8,135.92	53.25	81.94	50.32	-43.50
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debt to Equity	0.00	0.00	0.63	0.00	0.00
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.00
Current Ratio	12.02	5.89	1.89	9.88	4.57
Quick Ratio	10.67	3.92	1.27	8.43	4.09
Interest Coverage	-12.22	165.16	2.81	1.24	-35.23

Operating Efficiency Ratios

	Axogen Inc (AXGN)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debtors to sales (%)	12.74	12.51	16.92	18.77	21.73
Asset Turnover	0.43	0.59	0.51	0.22	0.63
Receivable days	40.77	46.54	58.79	72.41	60.95
Inventory Days	238.50	331.92	64.13	146.53	193.84
Payable days	34.39	26.16	58.13	29.05	60.19
Cash Conversion Cycle	244.87	352.30	64.79	189.88	194.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly